Mirae Asset Global Etfs Holdings Ltd. Capricor Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,551 shares of CAPR stock, worth $220,505. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,551
Previous 25,750
0.77%
Holding current value
$220,505
Previous $356,000
32.02%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CAPR
# of Institutions
141Shares Held
17.2MCall Options Held
1.51MPut Options Held
1.02M-
Vanguard Group Inc Valley Forge, PA2.26MShares$19.5 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$19.4 Million0.12% of portfolio
-
State Street Corp Boston, MA1.84MShares$15.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$14.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA901KShares$7.78 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $210M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...